Related Experiment Video
Updated: May 11, 2026

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
Published on: August 22, 2014
Platelet monoamine oxidase-A activity and aging: effect of carnosine
1Department of Biochemistry, University of Calcutta, 35, B.C. Road, Kolkata 700 019, India.
Abstract:
Platelet mitochondrial MAO-A activity of male albino rats (Wistar strain) was significantly inhibited with an inhibition of its only V max during aging. This age-induced inhibition of platelet MAO-A activity became reversed following the application of higher dosages (2.0-2.5 μg/kg/day, i.t. for 21 consecutive days) of carnosine. Though carnosine at lower dosage (0.5 μg/kg/day, i.t. for 21 consecutive days) was ineffective to platelet mitochondrial MAO-A activity in both young and aged rats, at higher dosages (2.0-2.5 μg/kg/day, i.t. for 21 consecutive days) under similar condition this enzyme activity was significantly enhanced. Carnosine at 1.0 μg/kg/day, i.t. for 21 consecutive days significantly enhanced MAO-A activity only in aged (18 and 24 months) rats. These results suggest that carnosine withdraws the aging-induced inhibition of mammalian blood platelet MAO-A activity and restores its activity towards that (MAO-A activity) observed in young mammalian blood platelets.
Insights
Carnosine supplementation can reverse age-related decline in platelet monoamine oxidase A (MAO-A) activity in rats. Higher carnosine doses restored enzyme function, suggesting potential therapeutic benefits for aging.
Area of Science:
- Biochemistry
- Gerontology
- Pharmacology
Background:
- Aging is associated with significant physiological changes, including alterations in enzyme activity.
- Platelet mitochondrial monoamine oxidase A (MAO-A) activity, crucial for neurotransmitter metabolism, declines with age.
- This age-induced inhibition of MAO-A is linked to reduced Vmax, impacting enzyme kinetics.
Purpose of the Study:
- To investigate the effect of carnosine on age-related changes in platelet mitochondrial MAO-A activity.
- To determine the dose-dependent efficacy of carnosine in modulating MAO-A activity in young and aged rats.
Main Methods:
- Male Wistar rats of varying ages (young, 18, and 24 months) were used.
- Administration of varying dosages of carnosine (0.5, 1.0, 2.0-2.5 μg/kg/day, intrathecally) for 21 consecutive days.
- Measurement of platelet mitochondrial MAO-A activity and its Vmax.
Main Results:
- Low-dose carnosine (0.5 μg/kg/day) had no significant effect on MAO-A activity in either young or aged rats.
- Higher carnosine doses (2.0-2.5 μg/kg/day) significantly enhanced MAO-A activity in aged rats, reversing age-induced inhibition.
- An intermediate dose (1.0 μg/kg/day) enhanced MAO-A activity specifically in aged rats.
Conclusions:
- Carnosine effectively counteracts the age-related inhibition of mammalian blood platelet MAO-A activity.
- Higher dosages of carnosine restore MAO-A activity to levels observed in younger individuals.
- Carnosine demonstrates potential as a therapeutic agent to mitigate age-associated declines in MAO-A function.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacodynamics in Geriatric Patients: Effects of Age
Mitochondria
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
The Effect of Aging on Tissues
